S&P 500   4,440.39 (-0.19%)
DOW   34,706.33 (-0.17%)
QQQ   371.34 (-0.44%)
AAPL   146.02 (-0.55%)
MSFT   297.71 (-0.62%)
FB   347.67 (+0.49%)
GOOGL   2,831.00 (+0.24%)
TSLA   762.47 (+1.17%)
AMZN   3,397.67 (-0.54%)
NVDA   218.92 (-2.62%)
BABA   145.67 (-3.65%)
NIO   35.43 (-1.61%)
CGC   13.95 (-4.19%)
GE   104.17 (+1.18%)
MU   74.33 (+0.39%)
AMD   105.03 (-1.06%)
T   27.25 (+0.22%)
F   13.94 (+1.68%)
ACB   6.00 (-2.44%)
DIS   175.40 (-0.48%)
PFE   44.06 (-0.29%)
BA   221.36 (+0.12%)
BAC   42.23 (+1.30%)
S&P 500   4,440.39 (-0.19%)
DOW   34,706.33 (-0.17%)
QQQ   371.34 (-0.44%)
AAPL   146.02 (-0.55%)
MSFT   297.71 (-0.62%)
FB   347.67 (+0.49%)
GOOGL   2,831.00 (+0.24%)
TSLA   762.47 (+1.17%)
AMZN   3,397.67 (-0.54%)
NVDA   218.92 (-2.62%)
BABA   145.67 (-3.65%)
NIO   35.43 (-1.61%)
CGC   13.95 (-4.19%)
GE   104.17 (+1.18%)
MU   74.33 (+0.39%)
AMD   105.03 (-1.06%)
T   27.25 (+0.22%)
F   13.94 (+1.68%)
ACB   6.00 (-2.44%)
DIS   175.40 (-0.48%)
PFE   44.06 (-0.29%)
BA   221.36 (+0.12%)
BAC   42.23 (+1.30%)
S&P 500   4,440.39 (-0.19%)
DOW   34,706.33 (-0.17%)
QQQ   371.34 (-0.44%)
AAPL   146.02 (-0.55%)
MSFT   297.71 (-0.62%)
FB   347.67 (+0.49%)
GOOGL   2,831.00 (+0.24%)
TSLA   762.47 (+1.17%)
AMZN   3,397.67 (-0.54%)
NVDA   218.92 (-2.62%)
BABA   145.67 (-3.65%)
NIO   35.43 (-1.61%)
CGC   13.95 (-4.19%)
GE   104.17 (+1.18%)
MU   74.33 (+0.39%)
AMD   105.03 (-1.06%)
T   27.25 (+0.22%)
F   13.94 (+1.68%)
ACB   6.00 (-2.44%)
DIS   175.40 (-0.48%)
PFE   44.06 (-0.29%)
BA   221.36 (+0.12%)
BAC   42.23 (+1.30%)
S&P 500   4,440.39 (-0.19%)
DOW   34,706.33 (-0.17%)
QQQ   371.34 (-0.44%)
AAPL   146.02 (-0.55%)
MSFT   297.71 (-0.62%)
FB   347.67 (+0.49%)
GOOGL   2,831.00 (+0.24%)
TSLA   762.47 (+1.17%)
AMZN   3,397.67 (-0.54%)
NVDA   218.92 (-2.62%)
BABA   145.67 (-3.65%)
NIO   35.43 (-1.61%)
CGC   13.95 (-4.19%)
GE   104.17 (+1.18%)
MU   74.33 (+0.39%)
AMD   105.03 (-1.06%)
T   27.25 (+0.22%)
F   13.94 (+1.68%)
ACB   6.00 (-2.44%)
DIS   175.40 (-0.48%)
PFE   44.06 (-0.29%)
BA   221.36 (+0.12%)
BAC   42.23 (+1.30%)
ASX:PNV

PolyNovo Stock Forecast, Price & News

Add
Compare
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
Volume3.38 million shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Receive PNV News and Ratings via Email

Sign-up to receive the latest news and ratings for PolyNovo and its competitors with MarketBeat's FREE daily newsletter.


About PolyNovo

Polynovo Limited develops medical devices in the United States, Australia, New Zealand, and internationally. The company offers NovoSorb Biodegradable Temporising Matrix, which is used in a fully debrided clean surgical wound to physiologically close the wound. It is also developing Syntrel hernia devices for hernia repair; breast devices in partnership with Establishment Labs; NovoSorb dermal beta cell implant in collaboration with BetaCell Technologies Pty Ltd; and NovoSorb drug elution depots. The company was formerly known as Calzada Limited and changed its name to Polynovo Limited in November 2014. Polynovo Limited was incorporated in 1998 and is based in Port Melbourne, Australia.

Headlines

See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous


MarketRank

Overall MarketRank

0.93 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.7Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











PolyNovo (ASX:PNV) Frequently Asked Questions

What stocks does MarketBeat like better than PolyNovo?

Wall Street analysts have given PolyNovo a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but PolyNovo wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Who are PolyNovo's key executives?

PolyNovo's management team includes the following people:
  • Mr. Paul Brennan, CEO, MD & Director
  • Mr. Jan-Marcel Gielen C.A., CFO & Company Sec.
  • Dr. Anthony Kaye, Chief Operating Officer
  • Ms. Katherine Napier, Marketing & Distributor Mang.
  • Ms. Monica Benyk, HR Mang.
  • Dr. Tim Moore, Principal Scientist
  • Mr. Edward Graubart, Sr. VP of North America

What other stocks do shareholders of PolyNovo own?

Based on aggregate information from My MarketBeat watchlists, some companies that other PolyNovo investors own include Immutep (IMMP), Rural Funds Group (RFF), Vanguard FTSE Pacific ETF (VPL), UQM Technologies (UQM), Tesla (TSLA), Starpharma (SPL), Moelis Australia (MOE), iSignthis (ISX), Align Technology (ALGN) and Acasti Pharma (ACST).

What is PolyNovo's stock symbol?

PolyNovo trades on the ASX under the ticker symbol "PNV."

How much money does PolyNovo make?

PolyNovo has a market capitalization of $0.00 and generates $29.16 million in revenue each year.

How many employees does PolyNovo have?

PolyNovo employs 91 workers across the globe.

What is PolyNovo's official website?

The official website for PolyNovo is www.polynovo.com.au.

How can I contact PolyNovo?

The company can be reached via phone at 61 3 8681 4050.


This page was last updated on 9/24/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.